Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of Toronto

$1,147,500.00

Targeting inhibitory neurotransmission to preserve cognition after surgery

FY 2025-26

Summary
We have all heard someone say, "Grandma (or Grandpa) was never quite the same after surgery." Among older adults, one of the most common and debilitating complications after surgery is a decline in brain function. Healthcare providers refer to such deficits as perioperative neurocognitive disorders. They include confusion, delirium and longer-term problems with memory, concentration and attention. These changes can last for weeks or months after the surgery, often leading to longer hospital stays, loss of independence and even increased risk of death. Yet there are currently no proven drug treatments to prevent or reverse them. Our goals are to understand why these problems occur and determine how to stop them. To address this urgent need, we established the world's first Perioperative Brain Health Centre at Sunnybrook Health Sciences Centre, which brings cutting-edge research from the laboratory bench to the patient's bedside. Our research focuses on a "memory-blocking" protein, a subtype of GABAA receptors, in the brain. Normally, this protein helps regulate learning and memory. However, our preliminary studies have shown two harmful changes that occur in the brain after surgery. First, nerve cells make too many of these memory-blocking receptors, and second, certain support cells (called astrocytes) make and release excess amounts of the chemical messenger that activates the receptors. Together, this "double hit" depresses the brain's memory circuits, making it harder to think and remember. To uncover how surgery triggers these changes, we will study mice using a range of experimental approaches. We will also test whether existing or new drugs can restore healthy brain function. Our results are expected to guide future clinical studies in patients, with the ultimate goal of protecting brain health and preserving independence for older adults after surgery.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
566304
Name
Orser Beverley A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Molecular & Cellular Neurosciences - B
Projecttitle
Targeting inhibitory neurotransmission to preserve cognition after surgery
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$1,147,500
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Astrocyte-Derived Gaba; Gaba-A Receptors; General Anesthetics; Hippocampus; Perioperative Neurocognitive Disorders; Surgery; Tonic Inhibition; Transgenic Mice
Abstract
We have all heard someone say, "Grandma (or Grandpa) was never quite the same after surgery." Among older adults, one of the most common and debilitating complications after surgery is a decline in brain function. Healthcare providers refer to such deficits as perioperative neurocognitive disorders. They include confusion, delirium and longer-term problems with memory, concentration and attention. These changes can last for weeks or months after the surgery, often leading to longer hospital stays, loss of independence and even increased risk of death. Yet there are currently no proven drug treatments to prevent or reverse them. Our goals are to understand why these problems occur and determine how to stop them. To address this urgent need, we established the world's first Perioperative Brain Health Centre at Sunnybrook Health Sciences Centre, which brings cutting-edge research from the laboratory bench to the patient's bedside. Our research focuses on a "memory-blocking" protein, a subtype of GABAA receptors, in the brain. Normally, this protein helps regulate learning and memory. However, our preliminary studies have shown two harmful changes that occur in the brain after surgery. First, nerve cells make too many of these memory-blocking receptors, and second, certain support cells (called astrocytes) make and release excess amounts of the chemical messenger that activates the receptors. Together, this "double hit" depresses the brain's memory circuits, making it harder to think and remember. To uncover how surgery triggers these changes, we will study mice using a range of experimental approaches. We will also test whether existing or new drugs can restore healthy brain function. Our results are expected to guide future clinical studies in patients, with the ultimate goal of protecting brain health and preserving independence for older adults after surgery.
Competitiondate
202603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Orser, Beverley A
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,147,500~ $0~